Skip to main content
. Author manuscript; available in PMC: 2014 Jan 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2012 Nov 9;266(2):233–244. doi: 10.1016/j.taap.2012.11.002

Figure 7. Vorinostat abrogates invasive tumor phenotype in A431 cells.

Figure 7

(A) Photographs showing scratch/wound healing assay after treatment with or without vorinostat (0.5 μM). Photographs are shown at 0 and 24 hrs. (B) Cell migration was checked by Boyden chamber assay with (0.5 μM) of vorinostat (10Xmagnification). (C) Graph for migration assay. Results expressed as percentage of migratory cells compared to control (±SE) per microscopic field (*p=0.010).